Department of Surgery, St. Luke's University Health Network, 801 Ostrum Street, Bethlehem, PA 18015, USA.
J Oncol. 2012;2012:707156. doi: 10.1155/2012/707156. Epub 2012 Nov 1.
Radioactive iodine (RAI) is used in treatment of patients with differentiated papillary and follicular thyroid cancer. It is typically used after thyroidectomy, both as a means of imaging to detect residual thyroid tissue or metastatic disease, as well as a means of treatment by ablation if such tissue is found. In this paper, we discuss the indications for and the mechanisms of RAI in the treatment of patients with thyroid cancer. We discuss the attendant risks and benefits that come with its use, as well as techniques used to optimize its effectiveness as an imaging tool and a therapeutic modality.
放射性碘（RAI）用于治疗分化型甲状腺癌（乳头状和滤泡状甲状腺癌）患者。RAI 通常在甲状腺切除术后使用，既是为了发现残留甲状腺组织或转移病灶而进行的成像手段，也是为了对这些组织进行消融治疗而使用的手段。本文讨论了 RAI 在甲状腺癌治疗中的适应证和作用机制，讨论了使用 RAI 带来的风险和获益，以及用于优化其作为成像工具和治疗方式的有效性的技术。
